COVID-19 and cystic fibrosis: Diagnostic difficulties or incorrect methods?
- Samuel Pecho-Silva,
- Ana Claudia Navarro-Solsol,
- Vicky Panduro-Correa,
- Kovy Arteaga-Livias,
- Alfonso J. Rodriguez-Morales(corresponding author),
- Kuldeep Dhama
- Hospital Nacional Edgardo Rebagliati Martins, EsSalud,
- Universidad Científica del Sur,
- Universidad Nacional de Ucayali,
- Universidad Nacional Hermilio Valdizán,
- ,
- Fundacion Universitaria Autonoma de las Américas
Research Output:
Contribution to journal
Article
Peer-review
Open access
Publication Information
Output type
Research Output:
Contribution to journal
Article
Peer-reviewOriginal language
EnglishPages from-to (Number of pages)
Pages 1681-1685 (5 pages)Journal (Volume, Issue Number)
Journal of Pure and Applied Microbiology (Volume 14, Issue 3)Publication milestones
- Published - 09/2020
Publication status
Published - 09/2020
ISSN
0973-7510Publication IDs
- Scopus: 85092595248
Abstract
Cystic fibrosis (CF) is a chronic lung disease with wide distribution worldwide. With the appearance of the Coronavirus Disease 2019 (COVID-19), caused by the Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2), difficulties arise when evaluating, diagnosing, and treating patients with other conditions, including CF. We present the case of a patient with CF who had a definite serological diagnosis, a CT scan suggestive of SARS-CoV-2 infection/COVID-19, and a negative molecular test (RT-PCR), with rapid resolution of symptoms and early discharge. CF/SARS-CoV-2 comorbidity needs to be adequately studied and assessed in the context of the COVID-19 pandemic.